Literature DB >> 24814879

Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report.

Tzu-Hua Lin1, Zhenyu Yao1, Taishi Sato1, Michael Keeney1, Chenguang Li1, Jukka Pajarinen1, Fan Yang2, Kensuke Egashira3, Stuart B Goodman4.   

Abstract

Total joint replacement (TJR) is very cost-effective surgery for end-stage arthritis. One important goal is to decrease the revision rate, mainly because TJR has been extended to younger patients. Continuous production of ultra-high molecular weight polyethylene (UHMWPE) wear particles induces macrophage infiltration and chronic inflammation, which can lead to periprosthetic osteolysis. Targeting individual pro-inflammatory cytokines directly has not reversed the osteolytic process in clinical trials, owing to compensatory up-regulation of other pro-inflammatory factors. It is hypothesized that targeting the important transcription factor NF-κB could mitigate the inflammatory response to wear particles, potentially diminishing osteolysis. In the current study, NF-κB activity in mouse RAW 264.7 and human THP1 macrophage cell lines, as well as primary mouse and human macrophages, was suppressed via competitive binding with double strand decoy oligodeoxynucleotide (ODN) containing an NF-κB binding element. It was found that macrophage exposure to UHMWPE particles induced multiple pro-inflammatory cytokine and chemokine expression, including TNF-α, MCP1, MIP1α and others. Importantly, the decoy ODN significantly suppressed the induced cytokine and chemokine expression in both murine and human macrophages, and resulted in suppression of macrophage recruitment. The strategic use of decoy NF-κB ODN, delivered locally, could potentially diminish particle-induced periprosthetic osteolysis.
Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Macrophage; NF-κB decoy oligodeoxynucleotide; Periprosthetic osteolysis; Wear particles

Mesh:

Substances:

Year:  2014        PMID: 24814879      PMCID: PMC4081023          DOI: 10.1016/j.actbio.2014.04.034

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  42 in total

Review 1.  Current concepts in osteolysis.

Authors:  B Ollivere; J A Wimhurst; I M Clark; S T Donell
Journal:  J Bone Joint Surg Br       Date:  2012-01

2.  Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.

Authors:  Marc Kalinowski; Kerstin Viehofer; Christine Hamann; James J Barry; Beate Kleb; Klaus Jochen Klose; Hans-Joachim Wagner; Heiko Alfke
Journal:  Cardiovasc Intervent Radiol       Date:  2005 May-Jun       Impact factor: 2.740

3.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response.

Authors:  Michael Keeney; Heather Waters; Katherine Barcay; Xinyi Jiang; Zhenyu Yao; Jukka Pajarinen; Kensuke Egashira; Stuart B Goodman; Fan Yang
Journal:  Biomaterials       Date:  2013-09-26       Impact factor: 12.479

5.  Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty.

Authors:  D H Sochart
Journal:  Clin Orthop Relat Res       Date:  1999-06       Impact factor: 4.176

6.  Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.

Authors:  Christophe Desmet; Philippe Gosset; Bernard Pajak; Didier Cataldo; Mohamed Bentires-Alj; Pierre Lekeux; Fabrice Bureau
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

7.  Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo.

Authors:  Edward M Schwarz; Debbie Campbell; Saara Totterman; Allen Boyd; Regis J O'Keefe; R John Looney
Journal:  J Orthop Res       Date:  2003-11       Impact factor: 3.494

Review 8.  The future of biologic coatings for orthopaedic implants.

Authors:  Stuart B Goodman; Zhenyu Yao; Michael Keeney; Fan Yang
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

9.  Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles.

Authors:  Fan Yang; Seung-Woo Cho; Sun Mi Son; Said R Bogatyrev; Deepika Singh; Jordan J Green; Ying Mei; Sohyun Park; Suk Ho Bhang; Byung-Soo Kim; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-05       Impact factor: 11.205

10.  Nuclear factor-κB modulates osteogenesis of periodontal ligament stem cells through competition with β-catenin signaling in inflammatory microenvironments.

Authors:  X Chen; C Hu; G Wang; L Li; X Kong; Y Ding; Y Jin
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

View more
  26 in total

1.  Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo.

Authors:  Xinyi Jiang; Taishi Sato; Zhenyu Yao; Michael Keeney; Jukka Pajarinen; Tzu-Hua Lin; Florence Loi; Kensuke Egashira; Stuart Goodman; Fan Yang
Journal:  J Orthop Res       Date:  2015-07-29       Impact factor: 3.494

2.  Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2017-07-21       Impact factor: 5.414

Review 3.  NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.

Authors:  T-H Lin; J Pajarinen; L Lu; A Nabeshima; L A Cordova; Z Yao; S B Goodman
Journal:  Adv Protein Chem Struct Biol       Date:  2016-12-09       Impact factor: 3.507

4.  Orthopaedic wear particle-induced bone loss and exogenous macrophage infiltration is mitigated by local infusion of NF-κB decoy oligodeoxynucleotide.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Luis A Córdova; Florence Loi; Emmanuel Gibon; Laura Lu; Karthik Nathan; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2017-09-13       Impact factor: 4.396

5.  NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model.

Authors:  Taishi Sato; Jukka Pajarinen; Tzu-hua Lin; Yasunobu Tamaki; Florence Loi; Kensuke Egashira; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2015-07-14       Impact factor: 4.396

6.  NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle.

Authors:  Tzu-Hua Lin; Taishi Sato; Katherine R Barcay; Heather Waters; Florence Loi; Ruth Zhang; Jukka Pajarinen; Kensuke Egashira; Zhenyu Yao; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2015-01-22       Impact factor: 3.845

7.  Suppression of NF-κB signaling mitigates polyethylene wear particle-induced inflammatory response.

Authors:  Tzu-Hua Lin; Stuart B Goodman
Journal:  Inflamm Cell Signal       Date:  2014

8.  NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model.

Authors:  Tzu-Hua Lin; Jukka Pajarinen; Taishi Sato; Florence Loi; Changchun Fan; Luis A Córdova; Akira Nabeshima; Emmanuel Gibon; Ruth Zhang; Zhenyu Yao; Stuart B Goodman
Journal:  Acta Biomater       Date:  2016-05-31       Impact factor: 8.947

9.  NFκB sensing IL-4 secreting mesenchymal stem cells mitigate the proinflammatory response of macrophages exposed to polyethylene wear particles.

Authors:  Tzuhua Lin; Yusuke Kohno; Jhih-Fong Huang; Monica Romero-Lopez; Jukka Pajarinen; Masahiro Maruyama; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2018-08-07       Impact factor: 4.396

10.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.